Literature DB >> 6820015

Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.

R S Baltimore, K Radnay-Baltimore, A von Graevenitz, T F Dolan.   

Abstract

There have been no comprehensive microbiologic studies of the frequency of respiratory colonization with nonfermentative gram-negative rods (NFGNR) other than Pseudomonas aeruginosa in patients with cystic fibrosis (CF). Records of bacteria isolated from throats and sputa of CF patients of the Yale-New Haven Hospital CF Clinic from 1975-1979 were reviewed in order to determine the incidence of these species. Thirty-one strains were recovered. Twenty patients from the CF Clinic (with an average census of 170 patients) yielded at least one isolate of non-P. aeruginosa NFGNR, and eight of them showed more than one species on at least one occasion. Two patients also carried P. aeruginosa and ten carried Staphylococcus aureus on at least one occasion. Using a standardized method of clinical scoring, our patients had a course not unlike our general CF population.

Entities:  

Mesh:

Year:  1982        PMID: 6820015

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  10 in total

1.  Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.

Authors:  M J Ledson; M J Gallagher; M Jackson; C A Hart; M J Walshaw
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

2.  In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.

Authors:  C Lewin; C Doherty; J Govan
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

3.  Stenotrophomonas maltophilia in cystic fibrosis patients.

Authors:  S Ballestero; I Vírseda; H Escobar; L Suárez; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

4.  Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Authors:  A Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

Review 5.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.

Authors:  G Manno; E Ugolotti; M L Belli; M L Fenu; L Romano; M Cruciani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

Review 7.  Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period.

Authors:  G Funke; T Hess; A von Graevenitz; P Vandamme
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

Review 9.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

10.  Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.

Authors:  F Karpati; A S Malmborg; H Alfredsson; L Hjelte; B Strandvik
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.